Controversies after a study by the Health Organization questioning the effectiveness… – AlKhaleej Today

A controversy erupted on Friday, after a clinical trial of the World Health Organization concluded that the anti-viral drug Remdesivir had little effect on the chances of survival for Covid-19 patients.
The American company, Gilead Sciences, which developed the drug, said that these results seem to contradict the evidence in other studies that have proven the clinical benefit of remdesivir, which was used as a drug to treat US President Donald Trumps infection with Corona.
The company said: …

Click here to view the original article.